Article
Cancer-driven IgG promotes the development of castration-resistant Prostate Cancer though the SOX2-CIgG pathway
2020-05-28
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Although Androgen deprivation therapy (ADT) is the initial treatment strategy for prostate cancer, recurrent castration-resistant prostate cancer (CRPC) eventually ensues. In this study, cancer-derived immunoglobulin G(CIgG) was found to be induced after ADT, identifying CIgG as a potential CRPC driver gene.<bold>Methods:</bold> The expression of CIgG and its cl...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4be1237-5d1a-5f41-a796-a3e044b044bc
- DOI
- 10.21203/rs.3.rs-31159/v1
